442 results on '"Eggener, Scott"'
Search Results
2. Robot-Assisted Retroperitoneal Lymph Node Dissection (RPLND)
3. Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion
4. MP41-15 GERMLINE DNA DAMAGE REPAIR GENE MUTATIONS IN EARLY STAGE PROSTATE CANCER PATIENTS UNDERGOING ACTIVE SURVEILLANCE OR DEFINITIVE LOCAL TREATMENT
5. PD29-09 PROSTATE CANCER AND SOLID ORGAN TRANSPLANTATION: PATIENT MANAGEMENT AND OUTCOMES
6. PD50-10 FREE PSA AND RISK OF GLEASON GRADE GROUP ≥2 AND FATAL PROSTATE CANCER IN BLACK MEN: IMPLICATIONS FOR RISK-STRATIFIED SCREENING
7. MP01-12 ACCURACY OF FDG-PET SCAN IN PRIMARY TESTICULAR SEMINOMA: ANALYSIS FROM SEMS TRIAL
8. Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1
9. Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2
10. Hormonal therapy and radiation therapy in prostate cancer: 5-year outcomes from a trial evaluating combined androgen blockade with 5-alpha reductase inhibitors as an alternative to gonadotropin releasing hormone agonists
11. Ex-vivo microscopic oncotesticular sperm extraction: step-by-step surgical technique at time of radical orchiectomy
12. PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
13. Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction
14. The influence of the “cancer” label on perceptions and management decisions for low-grade prostate cancer
15. SWOG S1823/CCTG GCC1: Translational observational investigational study of the liquid biomarker microRNA 371a-3p in newly diagnosed germ cell tumours—Real-world trial design, rapid accrual, and robust secondary use of data opportunities.
16. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening
17. Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy
18. Renaming Grade Group 1 Prostate “Cancer” From a Pathology Perspective: A Call for Multidisciplinary Discussion
19. MP33-01 RISK OF RESIDUAL TERATOMA AFTER COMPLETE RESPONSE FOLLOWING FIRST-LINE CHEMOTHERAPY IN MEN WITH METASTATIC NON-SEMINOMATOUS GERM CELL TUMOR AND IGCCCG INTERMEDIATE/POOR PROGNOSIS: A MULTI-INSTITUTIONAL RETROSPECTIVE COHORT STUDY
20. Physician Perception of Grade Group 1 Prostate Cancer
21. LBA02-11 UPDATED PROGRESSION-FREE SURVIVAL FROM PRESTO: A PHASE 3 RANDOMIZED STUDY OF ANDROGEN ANNIHILATION FOR HIGH-RISK BIOCHEMICALLY RELAPSED PROSTATE CANCER (AFT-19)
22. MP50-16 ONCOLOGICAL OUTCOMES FOLLOWING ROBOTIC POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR CANCER: A WORLDWIDE MULTICENTER STUDY
23. MP33-18 SURGICAL AND ONCOLOGIC OUTCOMES OF SURGERY IN EARLY METASTATIC SEMINOMA: MULTI-INSTITUTIONAL RETROSPECTIVE STUDY
24. Reply to X. Farré et al
25. MP73-05 PIVOTAL STUDY OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) OF LOCALIZED PROSTATE CANCER: 4-YEAR FOLLOW UP
26. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy
27. Reply to M. Baboudjian et al
28. Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19).
29. A population-based evaluation of tunica vaginalis mesothelioma: An analysis of the National Cancer Database
30. Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer Treatment
31. Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumor and IGCCCG intermediate/poor prognosis: a multi-institutional retrospective cohort study
32. Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue
33. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study
34. Testis Cancer
35. Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than Harm
36. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care
37. Low-Grade Prostate Cancer: Time to Stop Calling It Cancer
38. In-Bore Magnetic Resonance Imaging-Targeted Prostate Biopsy
39. Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy naïve men across racial/ethnic groups
40. Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes
41. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management
42. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions
43. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up
44. Reply by Authors
45. PD51-05 FEASIBILITY OF OMITTING CT PELVIS IN PATIENTS WITH STAGE I GERM CELL TUMOR (GCT) ON ACTIVE SURVEILLANCE: A MULTI-INSTITUTIONAL STUDY
46. PD51-01 CONTEMPORARY SURGICAL OUTCOMES OF RETROPERITONEAL LYMPH NODE DISSECTION FROM THE SEMS TRIAL
47. MP30-01 IMPACT AT 20 YEARS: IVUMED BY THE NUMBERS
48. MP30-05 THE PROJECTED IMPACT OF COVID-19 ON GLOBAL HEALTH SERVICES: TAXING AN ALREADY CRITICALLY LIMITED RESOURCE
49. PD03-04 SYSTEMATIC REVIEW OF THE IMPACT OF A PLANT-BASED DIET ON PROSTATE CANCER INCIDENCE AND OUTCOMES
50. How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.